PHARMACEUTICAL COMBINATION OF PDE5 INHIBITORS WITH ACE INHIBITORS

摘要

Combinations comprising a) an inhibitor of cyclic guanosine monophosphate (cGMP) specific phosphodiesterase type 5 (PDE5) inhibitor and b) an inhibitor of angiotensin converting enzyme (ACE) are useful for treating hypertension.